Fintel reports that on February 23, 2026, Jefferies downgraded their outlook for Freshworks (NasdaqGS:FRSH) from Buy to Hold.

Pliant Therapeutics trades at a deep discount to net cash after Bexotegrast's Phase 3 failure. Read why I am bullish about PLRX stock now.

SIG now holds over $1.3B in Bitcoin ETFs, including $1.09B in GBTC, while maintaining put positions against the Canary XRP ...

Susquehanna has revealed its spot Bitcoin ETF holdings and confirms long-term commitment to Bitcoin, while it hold puts ...

When one hears that some of the leading lights of the investing world — like Warren Buffett, Ray Dalio, and Ken Griffin — have sold off shares of a company, it certainly leaves an impact. That's the ...

Prior to the launch of the spring offseason schedule on Friday, Feb. 13, The Citadel football head coach Maurice Drayton solidified the full slate of additions -- a senior advisor, two full-time ...

Wall Street has shifted its interests from partnering with DeFi protocols to buying governance tokens and controlling infrastructure in core protocols.

Citrini founder James van Geelen has described the 2028 outlook as a hypothetical scenario, not a formal prediction.

A stock that hasn't exactly been a favorite among individual investors of late still managed to attract some noteworthy ...

Indian officials are tightening regulations on the booming options market to prevent excessive risk and protect household ...